Nipro (8086.T) Stock Price
Nipro Price
Nipro (8086.T) Stock | ISIN JP3673600007 | WKN 875746. The current Nipro stock price is 1,612 JPY (2026). Revenue is 675.21 B JPY. Net income is 15.47 B JPY. The P/E ratio is 19.18. Market capitalization is 296.69 B JPY. Nipro operates in the Health sector.
Revenue has compounded at 6.2% per year over the past 19 years to 644.59 B JPY. Earnings per share have declined at 1.1% per year over the last 19 years. Nipro's net margin stands at 0.8%, down from 3.1% several years earlier. Nipro currently offers a dividend yield of about 1.43%. The payout ratio is around 34% of earnings.
Nipro stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Nipro over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Nipro stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Nipro's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Nipro Price |
|---|
Nipro Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B JPY) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B JPY) |
| NET INCOME (B JPY) |
| NET INCOME GROWTH (%) |
| DIVIDEND (JPY)DIV. (JPY) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 455.56 | 494.79 | 545.2 | 586.79 | 644.59 | 675.21 | 696.31 | 749.58 |
| 2.95 | 8.61 | 10.19 | 7.63 | 9.85 | 4.75 | 3.13 | 7.65 |
| 30.48 | 30.17 | 29.98 | 29.2 | 29.61 | 28.27 | 27.41 | 25.47 |
| 138.84 | 149.27 | 163.45 | 171.32 | 190.88 | 190.88 | 190.88 | 190.88 |
| 14.21 | 13.46 | 4.57 | 11.11 | 5.11 | 15.47 | 16.22 | 22.44 |
| -215.7 | -5.31 | -66.01 | 142.87 | -53.97 | 202.48 | 4.86 | 38.38 |
| 21 | 26 | 18.5 | 27 | 23 | 18 | 30.58 | 42.19 |
| 100 | 23.81 | -28.85 | 45.95 | -14.81 | -21.74 | 69.89 | 37.97 |
| 163.1 | 173.79 | 184.08 | 184.08 | 184.05 | 184.05 | 184.05 | 184.05 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Nipro generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Nipro retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Nipro's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Nipro has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Nipro's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Nipro stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro business model & stock analysis
Nipro SWOT Analysis
Strengths
Nipro Corp has a strong market position and brand recognition, which gives it a competitive edge. The company has a diversified product portfolio across medical devices, pharmaceuticals, and healthcare services, reducing its dependence on a single segment. Nipro Corp has a strong focus on innovation and invests in research and development to introduce new and improved products. It also benefits from a global presence, with a widespread distribution network.
Weaknesses
Nipro Corp faces some weaknesses such as potential regulatory challenges in different countries, which may impact its operations. Lack of diversification in terms of geographical presence exposes the company to risks associated with specific regions. Additionally, Nipro Corp may face cost pressures due to increasing competition, evolving technologies, and changing customer preferences.
Opportunities
Nipro Corp can seize opportunities in the growing healthcare industry, especially in emerging markets, by offering affordable and innovative products tailored to local needs. The increasing prevalence of chronic diseases and aging populations worldwide provides a significant market for Nipro Corp's medical devices and healthcare services. Additionally, collaborations and partnerships with healthcare providers or organizations can enhance Nipro Corp's capabilities and expand its reach.
Threats
Nipro Corp faces threats from intense competition in the healthcare sector, both from established players and new entrants. Economic fluctuations and healthcare reforms in different countries may also impact the company's financial performance. Additionally, stringent regulatory requirements and product safety standards pose challenges to Nipro Corp's operations.
Nipro Eulerpool Fair Value
Nipro historical P/E ratio, EBIT multiple, and P/S ratio
Nipro annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Nipro shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro Dividend History
30 years of dividend payments
Nipro dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Nipro Earnings Estimates
Nipro Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/9/2024 | 13.53JPY | 151.03 BJPY | 2024 Q4 |
| 2/6/2024 | 22.32JPY | 154.96 BJPY | 2024 Q3 |
| 8/10/2021 | -JPY | 117.28 BJPY | 2022 Q1 |
| 5/11/2021 | -JPY | 117.65 BJPY | 2021 Q4 |
| 2/8/2021 | -JPY | 122.31 BJPY | 2021 Q3 |
| 11/9/2020 | 26.06JPY | 117.89 BJPY | 2021 Q2 |
| 8/7/2020 | 19.19JPY | 116.07 BJPY | 2021 Q1 |
| 5/11/2020 | -JPY | 115.99 BJPY | 2020 Q4 |
| 2/6/2020 | -JPY | 119.36 BJPY | 2020 Q3 |
| 11/7/2019 | -JPY | 110.43 BJPY | 2020 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Nipro stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Nipro shareholder structure
| % | Name |
|---|---|
5.55002% | |
4.41814% | |
2.84483% | |
2.58023% | |
2.55035% | |
2.27478% | |
2.0111% | |
1.7696% | |
1.6078% | |
1.44958% |
Nipro Executives and Management Board
Mr. Yoshihiko Sano
(79)President, Representative Director · since 2000
Mr. Takehito Yogo
(55)Senior Managing Director, Chief Director of Administration Supervision & Management Planning · since 2018
Mr. Yasushi Ohyama
(61)Senior Managing Director, Director of Vascular Business, President of Subsidiary · since 2013
Mr. Tsuyoshi Yamazaki
(56)Senior Managing Director, Director of International Business and International Business Supervision, President of Subsidiary · since 2009
Mr. Kiyotaka Yoshioka
(71)Senior Managing Director, Director of Domestic Business in Domestic Business Supervision · since 2006
Nipro Supply Chain
Frequently asked questions about Nipro
Nipro Corp, a leading Japanese company, operates in the healthcare industry, focusing on medical equipment and pharmaceutical products. With a diverse business model, Nipro Corp manufactures and sells various medical devices, including renal and infusion solutions, blood purification systems, and diabetes care products. Their pharmaceutical division is involved in the development and sales of generic drugs and therapeutic pharmaceuticals. Through strategic partnerships and acquisitions, Nipro Corp continues to expand its global presence and enhance its product offerings. As a renowned healthcare company, Nipro Corp remains committed to improving patient outcomes and contributing to the advancement of medical science worldwide.
Nipro stock
Nipro Peer Group
Nipro Ticker
Nipro FIGI
All fundamentals and in-depth analysis of Nipro
Our stock analysis for Nipro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nipro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.